Jane Street’s PureTech Health PRTC Stock Holding History

Jane Street’s Portfolio PRTC Stock Details PRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,739	Closed	-$247K	–	9677
2023 Q3	$247K	Buy	10,739 +608	+6%	+$16.3K	﹤0.01%	7337
2023 Q2	$280K	Buy	10,131 +499	+5%	+$13.8K	﹤0.01%	7240
2023 Q1	$263K	Buy	9,632 +1,289	+15%	+$38.2K	﹤0.01%	7410
2022 Q4	$269K	Buy	+8,343	New	+$248K	﹤0.01%	7201

Other funds holding PRTC

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's PRTC Position: Q4 2023 in Review

Jane Street sold out of PureTech Health (PRTC) in Q4 2023, closing a stake of 10,739 shares — an estimated $247K sold.

Jane Street first reported a position in PRTC in Q4 2022 and held it in 4 quarters. The position peaked at $280K in Q2 2023. 3 funds tracked by Wall St. Rank hold PRTC as of Q4 2023.

Jane Street reported no remaining PureTech Health position as of Q4 2023 after selling out during the quarter.
Jane Street sold 10,739 PureTech Health shares in Q4 2023, an estimated $247K.
Jane Street first reported a position in PureTech Health in Q4 2022 and held it in 4 quarters.
Jane Street's PureTech Health position peaked at $280K in Q2 2023.
3 funds tracked by Wall St. Rank held PureTech Health as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.